Although systemic EBV-positive T-cell lymphoma during childhood shares some clinicopathological features with ANKL, the two disease entities can be distinguished by their fundamentally distinct immunophenotypes—CD56+ NK cells vs. CD56− T cells. The gene discussed is NCAM1; the disease is aggressive NK-cell leukemia.